PTS International Inc. Report issue

For profit Phase 3
Founded: Monterey Park California United States (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2009
NCT03448146
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

PTS International Inc.

Active Ingredients

Drugs in Phase 3 Trials (1)

para-toluenesulfonamide (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 3)

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1